Emerging in the landscape of excess body fat treatment, retatrutide is a unique approach. Unlike many available medications, retatrutide works as a twin agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. The concurrent engagement encourages various advantageous effect… Read More